spinorphin (Human) [7420]
spinorphin (Human)
| SMILES |
CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(C)C |
| InChIKey |
BXIFNVGZIMFBQB-DYDSHOKNSA-N |
| Sequence |
LVVYPWT |
| HELM |
PEPTIDE1{L.V.V.Y.P.W.T}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
10 |
| Hydrogen bond donors |
10 |
| Rotatable bonds |
21 |
| Log P |
1.224 |
| Molecular weight (Da) |
876.5 |
| Stereochemistry info |
partial |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Endogenous |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.